Arie Belldegrun raises $300M, grabs Pfizer’s allogeneic CAR-T portfolio and launches a groundbreaking drive to commercialization admin April 4, 2018 PR You Might Also Like In Israel, embryonic entrepreneurship is lifeblood, but growing companies a challenge June 1, 2017 ‘Greatest emerging market’? Cannabis-based drug R&D finally going mainstream May 27, 2019 10 breakthrough health techs emerging from Israel May 22, 2018
